We emphasize that 170 Papanicolaou samples from Uberlândia (Minas Gerais, Brazil) were clinically monitored for CIN+ lesions: 54.1% did not show cellular abnormalities, 21.2% were CIN1+, 10% were CIN2+, 13.5% were CIN3+, and 1.2% were classified as having adenocarcinoma. This evidence concerns the gene PDXP and adenocarcinoma.